PharmaBoardroom

Chris Lu – CEO, Laekna Therapeutics, China

Dr. Chris Lu, CEO and cofounder of Laekna Therapeutics, shares Laekna’s ambition to deliver cures and improve the quality of life of patients…

Tony Acciarito – President, Thermo Fisher Scientific China

Tony Acciarito, President of Thermo Fisher Scientific China, explains how he is delivering the company's mission of ‘enabling our customers to make…

Gunilla Osswald – CEO, BioArctic, Sweden

BioArctic is a Swedish biopharma company with the vision to become a world-leader in the research and development of disease-modifying treatments for…

US Medicare Vows to Increase Payments for Cell & Gene…

Medicare, a national health insurance program in the United States covering Americans aged 65 and older as well as younger people with disabilities,…

How US Healthcare Can Better Accommodate Cell & Gene…

PhRMA's Anne McDonald Pritchett PhD highlights the remarkable development of cell and gene therapies in recent years and the three ways in which the…

Advanced Therapy Medicinal Products: The Right Time for Hope?

Pierre Meulien of the Innovative Medicines Initiative (IMI) highlights why cell and gene therapies seem finally braced for mainstream adoption as well…

Felix Gutsche – President, Boehringer Ingelheim China

Boehringer Ingelheim veteran executive Felix Gutsche shares the first impressions of the China market since he joined in January 2019; the strategic…

Mental Health in China: A Tsunami Brewing?

“Mental health is currently a major problem in China, and will become an ever greater problem unless effective interventions are put in place.”…

Elisabeth Svanberg – Chief Development Officer, IXALTIS…

Elisabeth Svanberg MD, PhD, a seasoned industry expert, having worked for established MNCs such as Serono, BMS & J&J, now sits on the board of…

Stockholm: A Hidden Jewel of Life Sciences Innovation in Europe

Some of the key stakeholders in Swedish healthcare and life sciences outline why they feel Sweden's capital, Stockholm, is a rising star in life…

Thailand’s Growing Reputation as a Clinical Trials Hub

Thailand is becoming an increasingly attractive location for pharma companies to conduct clinical trials, with multinationals such as Novo Nordisk and…

Sweden’s BioArctic: A Potential Paradigm Shift in Alzheimer’s…

Swedish biotech BioArctic, in collaboration with Japanese firm Eisai, has seen positive Phase IIb results for its BAN2401 antibody – potentially the…

Tagged with HE